You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

27 search results for: COPD

ADVENT On Air | Many Faces of <b>COPD</b>: From Phenotypes to Endotypes

Podcast

ADVENT On Air | Many Faces of COPD: From Phenotypes to Endotypes

21 min

Pulmonology

Drs Nicola Hanania and Francesca Polverino explore the Many Faces of COPD: From Phenotypes to Endotypes.

ADVENT On Air | Role of Type 2 Inflammation in <b>COPD</b>

Podcast

ADVENT On Air | Role of Type 2 Inflammation in COPD

21 min

Pulmonology

Drs Stephanie Christenson and Jean Bourbeau explore the role of type 2 inflammation in Chronic Obstructive Pulmonary Disease (COPD).

expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

42 min

Pulmonology

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

What Are the Key Inflammatory Processes in Patients with <b>COPD</b>?

expert video

What Are the Key Inflammatory Processes in Patients with COPD?

2 min

Pulmonology

Dr. Klaus Rabe, MD, PhD, discusses the key inflammatory processes in patients with COPD and their implications for patient care.

Understanding IL-33: A Key Factor in <b>COPD</b> Pathogenesis

interactivity

Understanding IL-33: A Key Factor in COPD Pathogenesis

5 min

Pulmonology

Explore the role of IL-33 in COPD pathophysiology and its potential as a therapeutic target

ERS 2023 | The Impact of Type 2 Inflammation on <b>COPD</b>: Examining Its Role in Disease Pathophysiology

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

17 min

Pulmonology

Prof. Klaus Rabe and Dr. Stephanie Christenson explore COPD's clinical presentation through disease pathology, emphasizing its diverse inflammatory pathways.

expert video

GOLD 2023 | Clinical Presentation of COPD and Disease Burden

9 min

Pulmonology

Dr. Igor Barjaktarevic discusses the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of recognizing the heterogeneity of COPD.

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of <b>COPD</b>

expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

29 min

Pulmonology

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of recognizing the heterogeneity of COPD.

expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

10 min

Pulmonology

Dr Igor Barjaktarevic discusses the role of underlying inflammation in COPD pathology and associated clinical features and explore the importance of biomarker assessments and endotyping in COPD

Podcast

ADVENT On Air | Pulmonary Perspectives: Understanding COPD Patient Burden

24 min

Pulmonology

Professors Francesca Puggioni and Ian Pavord explore the burdens faced by patients afflicted with Chronic Obstructive Pulmonary Disease (COPD).

videoanimation

GOLD 2024 Diagnosis and Assessment of COPD

10 min

Pulmonology

This short video presentation outlines the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region